Earnings call transcript: Hope Bancorp beats EPS estimates, stock dips slightly in Q1 2026

Hope Bancorp reported Q1 2026 EPS of $0.23, topping estimates by 4.55%, but revenue missed at $141.02 million versus $145.3 million expected. Net income rose 40% year over year to $30 million, PPNR increased 43%, and the efficiency ratio improved to 67%, though shares slipped 0.16% pre-market on the mixed print. Management highlighted the pending SMBC Manubank acquisition, projected loan growth of over 20% for 2026, and continued deposit-cost relief of roughly 5-7 bps per quarter.

Analysis

The market is treating this as a quality-improvement story rather than a growth inflection, which is why the revenue miss matters more than the EPS beat. The real signal is that margin expansion is being funded by liability repricing and expense discipline, not by accelerating asset generation; that tends to be durable for a few quarters, but it is also easier for investors to fade once deposit betas normalize. The pending acquisition adds another layer: it can lift the growth rate on paper, but the more important second-order effect is that it forces management to moderate CRE exposure, which should help funding stability but caps near-term organic leverage.

The competitive takeaway is that HOPE is trying to move up the value chain in commercial banking while preserving a deposit-cost advantage in a more rate-neutral world. If execution holds, regional banks with weaker franchise depth could lose some middle-market relationships in Southern California, while SMBC gets a cleaner route to retain client adjacency without carrying the standalone banking unit. The key risk is integration timing: if closing slips or the acquired book is less accretive than expected, the market will likely re-rate the stock on the basis of still-expensive valuation rather than near-term EPS momentum.

Consensus likely underestimates how much of the current earnings trajectory is already “in the number.” The combination of a low-80s to mid-70s efficiency glide path, continued CD repricing, and a flat Fed means there may be limited upside surprise left before the acquisition closes. Conversely, the setup for 2027 is more interesting than 2026: if the deal closes on schedule and credit remains benign, earnings power can step up meaningfully, but that is a longer-dated catalyst and should not be chased at a premium multiple today.

Key Decisions for Investors

• Avoid chasing HOPE at current levels; if initiating, use a 3-6 month pullback strategy and target entry closer to a de-rating event or post-close uncertainty. Risk/reward is unfavorable while the stock screens expensive relative to near-term fundamentals.
• For existing longs, sell covered calls 1-2 quarters out to monetize elevated multiple and cap downside from a flat-to-slightly positive operating backdrop. Best suited for holders who want dividend carry while waiting for 2027 accretion.
• Pair trade: long HOPE / short a lower-quality regional bank with weaker deposit franchise and higher CRE concentration over the next 6-9 months. The trade works if investors continue rewarding liability discipline and balance-sheet de-risking.
• If you want exposure to the acquisition upside, buy HOPE Jan-2027 calls or call spreads rather than common stock. This captures the earn-back/acceleration story while limiting downside if closing slips or valuation compresses.
• Monitor SMBC-related catalysts and Southern California regional bank multiples; any sign of deal friction or CRE concentration pressure should be used to fade HOPE on strength rather than buy weakness.